Persistent expression of Notch2 delays gonadotrope differentiation

Molecular Endocrinology

Volumn 20, Issue 11, 2006, Pages 2898-2908

  Raetzman, Lori T ^a,f   Wheeler, Bayly S ^a   Ross, Shelley A ^b,g   Thomas, Paul Q ^b,c,e   Camper, Sally A ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d 4909 Buhl Building ^*  (United States)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; LUTEINIZING HORMONE; NOTCH2 RECEPTOR; THYROTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HYPOPHYSIS; HYPOPLASIA; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; TEMPORAL LOBE; TRANSGENE;

MUS MUSCULUS;

EID: 33751505045     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0394     Document Type: Article

References (60)

1. Zhu X, Lin CR, Prefontaine GG, Tollkuhn J, Rosenfeld MG 2005 Genetic control of pituitary development and hypopituitarism. Curr Opin Genet Dev 15:332-340
2. Watkins-Chow DE, Camper SA 1998 How many homeobox genes does it take to make a pituitary gland? Trends Genet 14:284-290
3. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips III JA, Rosenfeld MG 1998 Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18:147-149
4. Cogan JD, Wu W, Phillips 3rd JA, Arnhold IJ, Agapito A, Fofanova OV, Osorio MG, Bircan I, Moreno A, Mendonca BB 1998 The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 83:3346-3349
5. Fluck C, Deladoey J, Rutishauser K, Eble A, Marti U, Wu W, Mullis PE 1998 Phenotypic variability in familial combined pituitary hormone deficiency Caused by a PROP1 gene mutation resulting in the substitution of Arg-Cys at codon 120 (R120C). J Clin Endocrinol Metab 83:3727-3734
6. Deladoey J, Fluck C, Buyukgebiz A, Kuhlmann BV, Eble A, Hindmarsh PC, Wu W, Mullis PE 1999 "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 84:1645-1650
7. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG 1996 Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327-333
8. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA 1996 Anterior pituitary cells defective in the cell autonomous factor, df, undergo cell lineage specification but not expansion. Development 122:151-160
9. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA 1996 The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage specific cell proliferation. Mol Endocrinol 10:1570-1581
10. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA 2005 Role of PROP1 in pituitary gland growth. Mol Endocrinol 19:698-710
11. Tang K, Bartke A, Gardiner CS, Wagner TE, Yun JS 1993 Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice. Endocrinology 132:2518-2524
12. Nasonkin IO, Ward RD, Raetzman LT, Seasholtz AF, Saunders TL, Gillespie PJ, Camper SA 2004 Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 13:2727-2735
13. Anderson B, Pearse II RV, Jenne K, Sornson M, Lin S-C, Bartke A, Rosenfeld MG 1995 The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 172:495-503
14. Ward RD, Stone BM, Raetzman LT, Camper SA 2006 Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 20:1378-1390
15. Brinkmeier ML, Potok MA, Cha KB, Gridley T, Stifani S, Meeldijk J, Clevers H, Camper SA 2003 TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol 17:2152-2161
16. Raetzman LT, Ward R, Camper SA 2002 Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 129:4229-4239.
17. Raetzman LT, Ross SA, Cook S, Dunwoodie SL, Camper SA, Thomas PQ 2004 Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 265:329-340
18. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H 1999 Notch signalling controls pancreatic cell differentiation. Nature 400:877-881
19. Hald J, Hjorth JP, German MS, Madsen OD, Serup P, Jensen J 2003 Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. Dev Biol 260:426-437
20. Murtaugh LC, Stanger BZ, Kwan KM, Melton DA 2003 Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA 100:14920-14925
21. Lutolf S, Radtke F, Aguet M, Suter U, Taylor V 2002 Notch1 is required for neuronal and glial differentiation in the cerebellum. Development 129:373-385
22. Solecki DJ, Liu XL, Tomoda T, Fang Y, Hatten ME 2001 Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 31:557-568
23. Furukawa T, Mukherjee S, Bao ZZ, Morrow EM, Cepko CL 2000 Rax, Hes1, and Notch1 promote the formation of Muller glia by postnatal retinal progenitor cells. Neuron 26:383-394
24. Morrison SJ, Perez SE, Qiao Z, Verdi JM, Hicks C, Weinmaster G, Anderson DJ 2000 Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 101:499-510
25. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM 2001 Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675-3683
26. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T 1999 Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723-730
27. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T 2000 Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14:1343-1352
28. Kendall SK, Gordon DF, Birkmeier TS, Petrey D, Sarapura VD, O'Shea KS, Wood WM, Lloyd RV, Ridgway EC, Camper SA 1994 Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone α-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol 8:1420-1433
29. Brinkmeier ML, Gordon DF, Dowding JM, Saunders TL, Kendall SK, Sarapura VD, Wood WM, Ridgway EC, Camper SA 1998 Cell-specific expression of the mouse glycoprotein hormone α-subunit gene requires multiple interacting DNA elements in transgenic mice and cultured cells. Mol Endocrinol 12:622-633
30. Burrows HL, Birkmeier TS, Seasholtz AF, Camper SA 1996 Targeted ablation of cells in the pituitary primordia of transgenic mice. Mol Endocrinol 10:1467-1477
31. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG 1999 Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97:587-598
32. Charles MA, Saunders TL, Wood WM, Owens K, Parlow AF, Camper SA, Ridgway EC, Gordon DF 2006 Pituitary specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol 20:1366-1377
33. Suh H, Gage PJ, Drouin J, Camper SA 2002 Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development 129:329-337
34. Maier MM, Gessler M 2000 Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem Biophys Res Commun 275:652-660
35. Iso T, Kedes L, Hamamori Y 2003 HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194:237-255
36. Robert-Moreno A, Espinosa L, de la Pompa JL, Bigas A 2005 RBPjκ-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 132:1117-1126
37. Bottner A, Keller E, Kratzsch J, Stobbe H, Weigel JF, Keller A, Hirsch W, Kiess W, Blum WF, Pfaffle RW 2004 PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab 89:5256-5265
38. Pernasetti F, Toledo SP, Vasilyev VV, Hayashida CY, Cogan JD, Ferrari C, Lourenco DM, Mellon PL 2006 Impaired adrenocorticotrophin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 85:390-397
39. Ikeda H, Yoshimoto T 1991 Developmental changes in proliferative activity of cells of the murine Rathke's pouch. Cell Tissue Res 263:41-47
40. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD 2000 Control of endodermal endocrine development by Hes-1. Nat Genet 24:36-44
41. Japon MA, Rubinstein M, Low MJ 1994 In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 42:1117-1125
42. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen W-H, Nachtigal MW, Abbud R, Nilson JH, Parker KL 1994 The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 8:2302-2312
43. Holley SJ, Hall SB, Mellon PL 2002 Complementary expression of IGF-II and IGFBP-5 during anterior pituitary development. Dev Biol 244:319-328
44. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J 1996 Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGF1-A (Egr-1). Science 273:1219-1221
45. Topilko P, Levi G, Merlo G, Mantero S, Desmarquet C, Mancardi G, Charnay P 1997 Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res 50:702-712
46. Acampora D, Mazan S, Tuorto F, Avantaggiato V, Tremblay JJ, Lazzaro D, Carlo Ad, Mariano A, Macchia PE, Corte G, Macchia V, Drouin J, Bržlet P, Simeone A 1998 Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH, FSH and LH. Development 125:1229-1239
47. Quirk CC, Seachrist DD, Nilson JH 2003 Embryonic expression of the LHβ gene appears to be coupled to the transient appearance of p8, an HMG-related transcription factor. J Biol Chem 278:1680-1685
48. Cushman LJ, Watkins-Chow DE, Brinkmeier ML, Raetzman LT, Radak AL, Lloyd RV, Camper SA 2001 Persistent Prop1 expression delays gonadotrope differentiation and enhances pituitary tumor susceptibility. Hum Mol Genet 10:1141-1153
49. Vesper AH, Raetzman LT, Camper SA 2006 Role of prophet of Pit1 (PROP1) in gonadotrope differentiation and puberty. Endocrinology 147:1654-1663
50. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M 2004 The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911
51. Henderson AM, Wang SJ, Taylor AC, Aitkenhead M, Hughes CC 2001 The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. J Biol Chem 276:6169-6176
52. Sakamoto M, Hirata H, Ohtsuka T, Bessho Y, Kageyama R 2003 The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2 regulate maintenance of neural precursor cells in the brain. J Biol Chem 278:44808-44815
53. Belandia B, Powell SM, Garcia-Pedrero JM, Walker MM, Bevan CL, Parker MG 2005 Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 25:1425-1436
54. Jorgensen JS, Nilson JH 2001 AR suppresses transcription of the LHbeta subunit by interacting with steroidogenic factor-1. Mol Endocrinol 15:1505-1516
55. Elagib KE, Xiao M, Hussaini IM, Delehanty LL, Palmer LA, Racke FK, Birrer MJ, Shanmugasundaram G, McDevitt MA, Goldfarb AN 2004 Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2. Mol Cell Biol 24:7779-7794
56. de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E 1997 A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337:1597-1602
57. Achermann JC, Gu WX, Kotlar TJ, Meeks JJ, Sabacan LP, Seminara SB, Habiby RL, Hindmarsh PC, Bick DP, Sherins RJ, Crowley Jr WF, Layman LC, Jameson JL 1999 Mutational analysis of DAX1 in patients with hypogonadotropic hypogonadism or pubertal delay. J Clin Endocrinol Metab 84:4497-4500
58. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL 1999 A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 22:125-126
59. Leimeister C, Bach A, Woolf AS, Gessler M 1999 Screen for genes regulated during early kidney morphogenesis. Dev Genet 24:273-283
60. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25:402-408